Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to enhance the utility of the Orange Book to foster drug competition - FDA Press Releases

FDA announces new policies to ensure the Orange Book provides the greatest benefit to patients and providers, and generic drug developers.

from Food and Drug Administration--Press Releases http://bit.ly/2Gbo3ss
via IFTTT